首站-论文投稿智能助手
典型文献
CB2 receptor activation inhibits the phagocytic function of microglia through activating ERK/AKT-Nurrl signal pathways
文献摘要:
Neuroinflammation is closely related to the pathogenesis of neurodegenerative diseases.Activation of microglia,the resident immune cells in CNS,induces inflammatory responses,resulting in the release of neurotoxic molecules,which favors neuronal death and neurodegeneration.Nuclear receptor-related 1(Nurr1)protein,one of the orphan nuclear receptor superfamilies,is an emerging target for neuroprotective therapy.In addition,the anti-inflammatory function of cannabinoid(CB)receptors has attracted increasing interest.As both CB receptors(especially CB2 receptor)and Nurr1 exist in microglia,and regulate a number of same molecular points such as NF-KB,we herein explored the interplay between the CB2 receptor and Nurr1 as well as the regulatory mechanisms in microglial cells.We showed that the application of CB2 receptor agonists JWH015(1,10μM)significantly increased the nuclear Nurr1 protein in BV-2 cells and primary midbrain microglia.Overexpression of Nurr1 or application of Nurr1 agonist C-DIM12(10 μM)significantly increased the mRNA level of CB2 receptor in BV-2 cells,suggesting that positive expression feedback existing between the CB2 receptor and Nurr1.After 2-AG and JWH015 activated the CB2 receptors,the levels of p-ERK,p-AKT,p-GSK-3β in BV-2 cells were significantly increased.Using ERK1/2 inhibitor U0126 and PI3K/AKT inhibitor LY294002,we revealed that the amount of Nurr1 in the nucleus was upregulated through β-arrestin2/ERK1/2 and PI3K/AKT/GSK-3βsignaling pathways.With these inhibitors,we found a cross-talk interaction between the two pathways,and the ERK1/2 signaling pathway played a more dominant regulatory role.Furthermore,we demonstrated that when the CB2 receptor was activated,the phagocytic function of BV-2 cells was significantly weakened;the activation of Nurr1 also inhibited the phagocytic function of BV-2 cells.Pretreatment with the signaling pathway inhibitors,especially U0126,reversed the inhibitory effect of 2-AG on phagocytosis,suggesting that CB2 receptor may regulate the phagocytic function of microglia by activating Nurr1.In conclusion,CB2 receptor or/and Nurr1-mediated signal pathways play instrumental roles in the progress of phagocytosis,which are expected to open up new treatment strategies for neurodegenerative diseases.
文献关键词:
作者姓名:
Qi-wen Han;Qian-hang Shao;Xiao-tong Wang;Kai-li Ma;Nai-hong Chen;Yu-he Yuan
作者机构:
State Key Laboratory of Bioactive Substances and Functions of Natural Medicines,Institute of Materia Medica&Neuroscience Center,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China;Institute of Medical Biology,Chinese Academy of Medical Sciences and Peking Union Medical College,Kunming 650118,China
引用格式:
[1]Qi-wen Han;Qian-hang Shao;Xiao-tong Wang;Kai-li Ma;Nai-hong Chen;Yu-he Yuan-.CB2 receptor activation inhibits the phagocytic function of microglia through activating ERK/AKT-Nurrl signal pathways)[J].中国药理学报(英文版),2022(09):2253-2266
A类:
Nurrl,superfamilies,JWH015,DIM12
B类:
CB2,activation,inhibits,phagocytic,function,through,activating,AKT,pathways,Neuroinflammation,closely,related,pathogenesis,neurodegenerative,diseases,Activation,resident,immune,cells,CNS,induces,inflammatory,responses,resulting,release,neurotoxic,molecules,which,favors,neuronal,death,neurodegeneration,Nuclear,Nurr1,protein,one,orphan,nuclear,emerging,target,neuroprotective,therapy,In,addition,anti,cannabinoid,receptors,has,attracted,increasing,interest,both,especially,number,same,molecular,points,such,KB,herein,explored,interplay,between,well,regulatory,mechanisms,microglial,We,showed,that,application,agonists,significantly,increased,BV,primary,midbrain,Overexpression,suggesting,positive,feedback,existing,After,AG,activated,levels,GSK,were,Using,ERK1,U0126,PI3K,LY294002,revealed,amount,nucleus,was,upregulated,arrestin2,signaling,With,these,inhibitors,found,cross,talk,interaction,two,played,dominant,Furthermore,demonstrated,when,weakened,also,inhibited,Pretreatment,reversed,inhibitory,effect,phagocytosis,may,by,conclusion,mediated,instrumental,roles,progress,are,expected,open,new,strategies
AB值:
0.435799
相似文献
Globular adiponectin-mediated vascular remodeling by affecting the secretion of adventitial-derived tumor necrosis factor-αinduced by urotensin Ⅱ
Jun LI;Limin LUO;Yonggang ZHANG;Xiao DONG;Shuyi DANG;Xiaogang GUO;Wenhui DING-Department of Cardiology,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Division of Cardiology,Department of Internal Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,China;Division of Cardiology,Department of Internal Medicine,Peking University First Hospital,Beijing 100034,China;Department of Dermatology,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Department of Cardiovascular Diseases,the Second Affiliated Hospital,Shantou University Medical College,Shantou 515041,China
CX3C-chemokine receptor 1 modulates cognitive dysfunction induced by sleep deprivation
Xin Jiawei;Wang Chao;Cheng Xiaojuan;Xie Changfu;Zhang Qiuyang;Ke Yilang;Huang Xuanyu;Chen Xiaochun;Pan Xiaodong-Department of Neurology, Fujian Institute of Geriatrics, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, China;Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, Fujian 350001, China;Key Laboratory of Brain Aging and Neurodegenerative Diseases, Fujian Medical University, Fuzhou, Fujian 350001, China;School and Hospital of Stomatology, Fujian Medical University, Fuzhou, Fujian 350001, China;Department of Geriatrics, Fujian Institute of Geriatrics, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, China;Fujian Key Laboratory of Vascular Aging, Fujian Medical University, Fuzhou, Fujian 350001, China
EGFR signaling promotes nuclear translocation of plasma membrane protein TSPAN8 to enhance tumor progression via STAT3-mediated transcription
Xiaoqing Lu;Liwei An;Guangjian FanTi;Lijuan Zang;Weiyi Huang;Junjian Li;Jun Liu;Weiyu Ge;Yuwei Huang;Jingxuan Xu;Shaoqian Du;Yuan Cao;Tianhao Zhou;Huijing Yin;Li Yu;Shi Jiao;Hongxia Wang-State Key Laboratory of Oncogenes and Related Genes,Department of Oncology,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;Department of Breast Surgery,Shanxi Cancer Hospital,Chinese Academy of Medical Sciences,Taiyuan,Shanxi,China;Department of Medical Ultrasound,Shanghai Tenth People's Hospital,Tongji University Cancer Center,School of Medicine,Tongji University,Shanghai,China;Precision Research Center for Refractory Diseases,Institute for Clinical Research,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;Department of Pathology,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;State Key Laboratory of Membrane Biology,Tsinghua-Peking University Joint Center for Life Sciences,School of Life Science,Tsinghua University,Beijing,China;State Key Laboratory of Genetic Engineering,School of Life Sciences,Fudan University,Shanghai,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。